Author:
Naylor GS,Buckley DE,Boardman LJ,Smith AH,Moody JP
Abstract
1. There is evidence that erythrocyte Na+‐K+‐ATPase activity and erythrocyte cyclic AMP change on recovery from a depressive illness. Mianserin is a recently introduced antidepressant but its mode of action is unknown. The present study was therefore designed to investigate in vivo the effect of mianserin on erythrocyte Na+‐K+‐ ATPase and cyclic AMP. 2. Biochemical estimations were made on blood from depressed patients before beginning either mianserin or matched placebo treatment, after 1 week, and again after 2 weeks' treatment. 3. Neither the erythrocyte Na+‐K+‐ATPase, nor the erythrocyte cyclic AMP concentration, changed significantly in either the mianserin‐ or the placebo‐treated group. 4. The study sheds no light on the possible mechanism of action of mianserin.
Subject
Pharmacology (medical),Pharmacology